Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicolas Albin1, Frédéric Chassagnol2, Jean-François Bergmann3

  • 1Groupe hospitalier mutualiste de Grenoble, institut Daniel Hollard, 8, rue Docteur-Calmette, CS10043, 38028 Grenoble cedex 1, France; ANSM, 93285 Saint-Denis, France.

Therapie
|January 8, 2019
PubMed
Summary

No abstract available in PubMed .

Keywords:
Accès précocesAutorisation de mise sur le marchéAutorisation temporaire d’utilisationConseil stratégique des industries de santéInnovationRemboursement

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supporting the Implementation and Addressing the Challenges of the EU HTA Regulation.

Journal of market access & health policy·2026
Same author

Therapie·2026
Same author

How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?

Therapie·2026
Same author

Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study.

Journal of investigational allergology & clinical immunology·2025
Same author

PD-L1 inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: a French nationwide cohort study.

The Lancet regional health. Europe·2025
Same author

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2025